These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 17691950)

  • 21. Estrogen and prostate cancer: an eclipsed truth in an androgen-dominated scenario.
    Carruba G
    J Cell Biochem; 2007 Nov; 102(4):899-911. PubMed ID: 17786930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of novel daunorubicin-estrogen conjugates.
    Kasiotis KM; Magiatis P; Pratsinis H; Skaltsounis A; Abadji V; Charalambous A; Moutsatsou P; Haroutounian SA
    Steroids; 2001 Oct; 66(10):785-91. PubMed ID: 11522342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeted polymers for gene delivery.
    Hughes JA; Rao GA
    Expert Opin Drug Deliv; 2005 Jan; 2(1):145-57. PubMed ID: 16296741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen Receptor Ligands: A Review (2013-2015).
    Farzaneh S; Zarghi A
    Sci Pharm; 2016 Apr; 84(3):409-427. PubMed ID: 28117309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-tumor efficiency of paclitaxel and DNA when co-delivered by pH responsive ligand modified nanocarriers for breast cancer treatment.
    Yu D; Li W; Zhang Y; Zhang B
    Biomed Pharmacother; 2016 Oct; 83():1428-1435. PubMed ID: 27592131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estrogen-derived steroidal metal complexes: agents for cellular delivery of metal centers to estrogen receptor-positive cells.
    Jackson A; Davis J; Pither RJ; Rodger A; Hannon MJ
    Inorg Chem; 2001 Jul; 40(16):3964-73. PubMed ID: 11466055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estrogens and anti-estrogens: key mediators of prostate carcinogenesis and new therapeutic candidates.
    Ho SM
    J Cell Biochem; 2004 Feb; 91(3):491-503. PubMed ID: 14755680
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection of Endogenous Selective Estrogen Receptor Modulators such as 27-Hydroxycholesterol.
    Nelson ER
    Methods Mol Biol; 2016; 1366():431-443. PubMed ID: 26585155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted anticancer therapy: overexpressed receptors and nanotechnology.
    Akhtar MJ; Ahamed M; Alhadlaq HA; Alrokayan SA; Kumar S
    Clin Chim Acta; 2014 Sep; 436():78-92. PubMed ID: 24836529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor ligands: a patent review update.
    Paterni I; Bertini S; Granchi C; Macchia M; Minutolo F
    Expert Opin Ther Pat; 2013 Oct; 23(10):1247-71. PubMed ID: 23713677
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacology of estrogens and estrogen-induced effects on nonreproductive organs and systems.
    Gorrill MJ; Marshall JR
    J Reprod Med; 1986 Sep; 31(9 Suppl):842-7. PubMed ID: 3772905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling by estrogens.
    Cheskis BJ; Greger JG; Nagpal S; Freedman LP
    J Cell Physiol; 2007 Dec; 213(3):610-7. PubMed ID: 17886255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The use of high-dose estrogens for the treatment of breast cancer.
    Coelingh Bennink HJ; Verhoeven C; Dutman AE; Thijssen J
    Maturitas; 2017 Jan; 95():11-23. PubMed ID: 27889048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ligands for the estrogen receptor, containing cyclopentadienyltricarbonylrhenium units.
    Spradau TW; Katzenellenbogen JA
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3235-40. PubMed ID: 9873709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Drug delivery system for the treatment of osteoporosis].
    Satoh T; Yoshida G; Orito Y; Koike T
    Nihon Rinsho; 1998 Mar; 56(3):742-7. PubMed ID: 9549367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence of estrogens and estrogen receptor-like proteins in Solanum glaucophyllum.
    Milanesi L; Monje P; Boland R
    Biochem Biophys Res Commun; 2001 Dec; 289(5):1175-9. PubMed ID: 11741316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microfluidics: a focus on improved cancer targeted drug delivery systems.
    Khan IU; Serra CA; Anton N; Vandamme T
    J Control Release; 2013 Dec; 172(3):1065-74. PubMed ID: 23933524
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel ligands that function as selective estrogens or antiestrogens for estrogen receptor-alpha or estrogen receptor-beta.
    Sun J; Meyers MJ; Fink BE; Rajendran R; Katzenellenbogen JA; Katzenellenbogen BS
    Endocrinology; 1999 Feb; 140(2):800-4. PubMed ID: 9927308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of computational modeling approaches in studying the binding interactions of compounds with human estrogen receptors.
    Wang P; Dang L; Zhu BT
    Steroids; 2016 Jan; 105():26-41. PubMed ID: 26639429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.